Home > Insider Trading > Filing (0001144204-13-025804)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1518647	P Robert Gasparini	C/O Neogenomics, Inc. 12701 Commonwealth Drive Suite 9 Fort Myers FL US 33913	Chief Science Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-04-29	50,000	$0.25	50,000	No	4	A	Direct
Common Stock	Disposition	2013-04-29	25,000	$3.80	25,000	No	4	S	Direct
Common Stock	Disposition	2013-04-30	5,000	$3.75	20,000	No	4	S	Direct
Common Stock	Disposition	2013-05-01	7,500	$3.56	12,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2013-04-29	50,000	$0.00	0	$0.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
525,000	2005-01-03	2015-01-03	No	4	X	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$1.47	2007-02-13	2017-02-12	100,000	Direct
Common Stock	Stock Option (right to buy)	$0.80	2008-03-12	2015-03-12	584,000	Direct
Common Stock	Stock Option (right to buy)	$0.62	2009-12-31	2016-02-01	150,000	Direct

Expiration Date	Remaning Holdings	Nature of Ownership
2017-02-12	100,000	Direct
2015-03-12	584,000	Direct
2016-02-01	150,000	Direct

Footnotes

On March 12, 2008 Mr. Gasparini was granted an option to purchase 784,000 shares. The first vesting and exercisable date was March 12, 2008. On this date 24,000 options vested and then there was to be 45 additional monthly vesting of 8,000 shares for a total of 384,000 options. Included in this grant were 400,000 non-qualified options with an initial vesting on March 12, 2008. From this grant 200,000 options were cancelled. In terms of the remaining 200,000 non-qualified options, 100,000 options are vested and exercisable.
On February 2, 2009 Mr. Gasparini was granted an option to purchase 200,000 shares. These were performance options which vest based on various milestones. To date 50,000 shares are vested and exercisable, 50,000 shares have been cancelled and 100,000 shares are unvested.